|
|
|
| Genetic analysis of the pedigree with inherited coagulation factorXII deficiency caused by compound heterozygous mutations |
| LI Shaoxi, LI Xiaolong, JIN Yanhui, YANG Lihong, ZHANG Haiyue, WANG Mingshan |
| Center of Laboratory Medcine, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China |
|
| Cite this article: |
|
LI Shaoxi,LI Xiaolong,JIN Yanhui, et al. Genetic analysis of the pedigree with inherited coagulation factorXII deficiency caused by compound heterozygous mutations[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2020, 50(2): 130-134.
|
|
|
|
Abstract Objective: To detect the laboratory phenotype and genotype of a hereditary factorXII (FXII) deficient pedigree caused by compound heterozygous mutations, which will help us to investigate the causative gene and its molecular pathogenesis. Methods: Prothrombin time (PT), activated partial thromboplastin time (APTT), coagulation factor VIII activity (FVIII:C), coagulation factor IX activity (FIX:C), coagulation factor XI activity (FXI:C), FXII activity (FXII:C), and FXII antigen (FXII:Ag) were assayed in proband and his family members (five persons in three generations) to confirm the diagnosis. All exons and flanking sequences of the F12 gene of the proband were analyzed by direct PCR sequencing. The mutation sites were confirmed by reverse sequencing and the corresponding mutation site regions of the family members were detected. The conservation of amino acid mutation sites were analyzed using ClustalX-2.1-win software, the effect of mutations on protein functions were analyzed using four online bioinformatic tools (Mutation Taster, Poly-Phen-2, PROVEAN and SIFT); the mutation sites were analyzed by Swiss-Pdb Viewer 4.0.1 for molecular structure and protein interaction. Results: The APTT of the proband is 59.1 s, prolonged obviously, and the FXII:C decreased to 4%, the FXII:Ag decreased to 5%; the FXII:C and the FXII:Ag of his father, mother and daughter decreased to 32%-37%. Genetic analysis revealed that there were two compound heterozygous mutations in exon 13 of the F12 gene in the proband: one was the c.1561G>A point heterozygous missense mutation (p.Glu502Lys); another was the c.1637T>C point heterozygous missene mutation (p.Met527Thr). His father was carried the p.Met527Thr mutation, his mother and daughter were carried the p.Glu502Lys mutation. Conservative analysis showed that Glu502 and Met527 were highly conserved among homologous species. The four online bioinformatics sofwares predicted results for these mutations were consistent: all predicted that these mutations were likely to be deleterious mutations that could cause related diseases. Mutant protein model analysis showed that wild-type Glu502 forms a hydrogen bond with His365, the mutant Lys502 resulted in the disappearance of the hydrogen bond between Lys502-His365. Replacement of Met527 with Thr527 resulted in the addition of two hydrogen bonds between Thr527-Leu527. Conclusion: There were two compound heterozygous mutations p.Glu502Lys and p.Met527Thr in exon 13 of the F12 gene in the proband, which were speculated that the heterozygous mutations were inherited from his parents with the heterozygotes of p.Glu502Lys and p.Met527Thr respectively and were associated with the reduced blood FXII levels in the family.
|
|
|
| |
|
|
|
[1] BJORKQVIST J, NICKEL K F, STAVROU E, et al. In vivo activation and functions of the protease factor XII[J]. Thromb Haemost, 2014, 112(5): 868-875.
[2] KWON M J, KIM H J, LEE K O, et al. Molecular genetic analysis of Korean patients with coagulation factor XII defi-ciency[J]. Blood Coagul Fibrinolysis, 2010, 21(4): 308-312.
[3] LOMBARDI A M, BORTOLETTO E, SCARPARO P, et al. Geneticstudy in patients with factor XII deficiency: a report ofthree new mutations exon 13 (Q501STOP), exon 14(P547L) and -13C>T promoter region in three compound heterozygotes[J]. Blood Coagul Fibrinolysis, 2008, 19(7): 639-643.
[4] 谢海啸, 王莹宇, 周武, 等. 凝血因子XII缺陷症导致再发体外受精和胚胎移植失败原因2例分析[J]. 温州医科大学学报, 2014, 44(4): 286-289.
[5] 谢海啸, 王明山, 谢耀盛, 等. 一个遗传性凝血因子XII缺陷症家系凝血因子XII基因分析[J]. 中华检验医学杂志, 2010, 33(4): 300-301.
[6] YANG L, WANG Y, ZHOU J, et al. Identification of genetic defects Underlying FXII deficiency in four Unrelated Chinese patients[J]. Acta Haematol, 2016, 135(4): 238-240.
[7] JIN P, JIANG W, YAN H, et al. Novel mutations in congenital factor XII deficiency[J]. Front Biosci (Landmark Ed), 2016, 21: 419-429.
[8] SCHLOESSER M, ZEERLEDER S, LUTZE G, et al. Mutations in the human factor XII gene[J]. Blood, 1997, 90(10): 3967-3977.
[9] SUZUKI K, MURAI K, SUWABE A, et al. Factor XII Ofunato: Lys346Asn mutation associated with blood coagulation factor XII deficiency causes impaired secretion through a proteasome-meadiated degradation[J]. Thromb Res, 2010, 125(5): 438-443.
|
| [1] |
YU Xiaomin,CHANG Guolin, ZHENG Yiyang, CHEN Cheng, TANG Shiyi, WU Xinyuan, LYU Jia, LIN Xiangyang, ZHU Liqing.. The pathogenic mechanism of inherited protein C deficiency caused by Ala333Thr mutation[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2022, 52(5): 352-357. |
|
|
|
|
